{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:53Z","timestamp":1707524633462},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,21]]},"DOI":"10.7759\/cureus.27102","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T13:55:36Z","timestamp":1658411736000},"source":"Crossref","is-referenced-by-count":0,"title":["Clostridium difficile Infection During Palliative Capecitabine Chemotherapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Keshav","family":"Bhattar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palack","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-016-0109-4","article-title":"Palliative chemotherapy: oxymoron or misunderstanding?","volume":"15","author":"Roeland EJ","year":"2016","unstructured":"Roeland EJ, LeBlanc TW. Palliative chemotherapy: oxymoron or misunderstanding?. BMC Palliat Care. 2016, 15:33. 10.1186\/s12904-016-0109-4","journal-title":"BMC Palliat Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70045-6","article-title":"Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review","volume":"12","author":"Oostendorp LJ","year":"2011","unstructured":"Oostendorp LJ, Stalmeier PF, Donders AR, van der Graaf WT, Ottevanger PB. Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review. Lancet Oncol. 2011, 12:1053-61. 10.1016\/S1470-2045(11)70045-6","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9645294","article-title":"Chemotherapy options beyond the first line in HER-negative metastatic breast cancer","volume":"2020","author":"Lorusso V","year":"2020","unstructured":"Lorusso V, Latorre A, Giotta F. Chemotherapy options beyond the first line in HER-negative metastatic breast cancer. J Oncol. 2020, 2020:9645294. 10.1155\/2020\/9645294","journal-title":"J Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363020-00009","article-title":"Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer","volume":"63","author":"Wagstaff AJ","year":"2003","unstructured":"Wagstaff AJ, Ibbotson T, Goa KL. Capecitabine: a review of its pharmacology and therapeutic efficacy in the management of advanced breast cancer. Drugs. 2003, 63:217-36. 10.2165\/00003495-200363020-00009","journal-title":"Drugs"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(14)70006-3","article-title":"Guidance on the management of diarrhoea during cancer chemotherapy","volume":"15","author":"Andreyev J","year":"2014","unstructured":"Andreyev J, Ross P, Donnellan C, et al.. Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol. 2014, 15:447-460. 10.1016\/s1470-2045(14)70006-3","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2004.06.006","article-title":"Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda)","volume":"8 Suppl 1","author":"Mars\u00e9 H","year":"2004","unstructured":"Mars\u00e9 H, Van Cutsem E, Grothey A, Valverde S. Management of adverse events and other practical considerations in patients receiving capecitabine (Xeloda). Eur J Oncol Nurs. 2004, 8 Suppl 1:S16-30. 10.1016\/j.ejon.2004.06.006","journal-title":"Eur J Oncol Nurs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-010-0525-x","article-title":"Ischemic colitis after capecitabine plus cisplatin treatment in advanced gastric cancer","volume":"31","author":"Cetin B","year":"2011","unstructured":"Cetin B, Buyukberber S, Sent\u00fcrk S, G\u00fczel E, Coskun U, Benekli M. Ischemic colitis after capecitabine plus cisplatin treatment in advanced gastric cancer. J Thromb Thrombolysis. 2011, 31:503-6. 10.1007\/s11239-010-0525-x","journal-title":"J Thromb Thrombolysis"},{"key":"ref8","article-title":"Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature","volume":"332","author":"Zou","unstructured":"Zou, Y., Liu, S., Wu, J. . Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature. World J Surg Onc 19. 332:","journal-title":"World J Surg Onc 19"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/BF02710173","article-title":"Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil","volume":"7","author":"Morales Chamorro R","year":"2005","unstructured":"Morales Chamorro R, Serrano Blanch R, M\u00e9ndez Vidal MJ, G\u00f3mez Espa\u00f1a MA, Rubio P\u00e9rez MJ, de la Haba Rodr\u00edguez JR, Aranda Aguilar E. Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil. Clin Transl Oncol. 2005, 7:258-61. 10.1007\/BF02710173","journal-title":"Clin Transl Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v2.i10.390","article-title":"Severe colitis associated with docetaxel use: a report of four cases","volume":"2","author":"Carrion AF","year":"2010","unstructured":"Carrion AF, Hosein PJ, Cooper EM, Lopes G, Pelaez L, Rocha-Lima CM. Severe colitis associated with docetaxel use: a report of four cases. World J Gastrointest Oncol. 2010, 2:390-4. 10.4251\/wjgo.v2.i10.390","journal-title":"World J Gastrointest Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/749789","article-title":"Lethal Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy in ovarian carcinoma: case report and review of the literature","volume":"2010","author":"Masciullo V","year":"2010","unstructured":"Masciullo V, Mainenti S, Lorusso D, Margariti PA, Scambia G. Lethal Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy in ovarian carcinoma: case report and review of the literature. Obstet Gynecol Int. 2010, 2010:10.1155\/2010\/749789","journal-title":"Obstet Gynecol Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7540302","article-title":"Recurrent pseudomembranous colitis in an ovarian cancer patient undergoing carboplatin chemotherapy","volume":"2016","author":"Allen VA","year":"2016","unstructured":"Allen VA, Manahan KJ, Geisler JP. Recurrent pseudomembranous colitis in an ovarian cancer patient undergoing carboplatin chemotherapy. Case Rep Obstet Gynecol. 2016, 2016:7540302. 10.1155\/2016\/7540302","journal-title":"Case Rep Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1086\/430311","article-title":"Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole","volume":"40","author":"Musher DM","year":"2005","unstructured":"Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, Borchert F, Hamill RJ. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis. 2005, 40:1586-90. 10.1086\/430311","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"McFarland LV","year":"2002","unstructured":"McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol. 2002, 97:1769-75. 10.1111\/j.1572-0241.2002.05839.x","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4253\/wjge.v11.i5.383","article-title":"Role of colonoscopy in diagnosis of capecitabine associated ileitis: two case reports","volume":"11","author":"Dao AE","year":"2019","unstructured":"Dao AE, Hsu A, Nakshabandi A, et al.. Role of colonoscopy in diagnosis of capecitabine associated ileitis: two case reports. World J Gastrointest Endosc. 2019, 11:383-8. 10.4253\/wjge.v11.i5.383","journal-title":"World J Gastrointest Endosc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14621","article-title":"Capecitabine-induced terminal ileitis: case report and literature review","volume":"13","author":"Klimko A","year":"2021","unstructured":"Klimko A, Tieranu CG, Olteanu AO, Preda CM, Ionescu EM. Capecitabine-induced terminal ileitis: case report and literature review. Cureus. 2021, 13:e14621. 10.7759\/cureus.14621","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.5899","article-title":"Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin","volume":"31","author":"Cornely OA","year":"2013","unstructured":"Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S. Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin. J Clin Oncol. 2013, 31:2493-9. 10.1200\/JCO.2012.45.5899","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur Y","year":"2012","unstructured":"Taur Y, Xavier JB, Lipuma L, et al.. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2012, 55:905-14. 10.1093\/cid\/cis580","journal-title":"Clin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2010.13.2.231","article-title":"Docetaxel-induced severe fluid retention in a breast cancer patient: a case report","volume":"13","author":"Jeon YS","year":"2010","unstructured":"Jeon YS, Kang SH, Lee SJ. Docetaxel-induced severe fluid retention in a breast cancer patient: a case report. J Breast Cancer. 2010, 13:231-235. 10.4048\/jbc.2010.13.2.231","journal-title":"J Breast Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99251-clostridium-difficile-infection-during-palliative-capecitabine-chemotherapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:09Z","timestamp":1707507369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99251-clostridium-difficile-infection-during-palliative-capecitabine-chemotherapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,21]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.27102","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,21]]}}}